Meditation Techniques: Mindfulness, TM, Body Scan, and the Four With Real Evidence

Meditation research has changed substantially in the last twenty years. What used to be dismissed as unmeasurable and unfalsifiable now has trials in the thousands, meta-analyses in JAMA and Lancet Psychiatry, and a set of practices with genuinely solid evidence for specific mental health outcomes. What has not changed is the industry around meditation, which continues to claim benefits well beyond what the trial base supports.

This article separates the two. Four meditation techniques have earned real trial support for specific outcomes. Several others have interesting preliminary support that has not yet matured into a firm evidence base. And some claims about meditation — especially the more expansive ones about longevity, chronic disease reversal, or transcendent states — remain outside what any current trial can support.

The four practices with real evidence

1. Mindfulness-Based Stress Reduction (MBSR)

The best-studied secular meditation program in the West. Developed by Jon Kabat-Zinn at UMass in the late 1970s, MBSR is an 8-week structured program combining sitting meditation, body scan, yoga, and mindful movement. Participants meditate for 30 to 45 minutes per day plus attend weekly group sessions.

Goyal and colleagues' 2014 JAMA Internal Medicine meta-analysis reviewed 47 trials of meditation programs with over 3,500 participants and found consistent moderate effect sizes for MBSR on anxiety, depression, and pain. Effect sizes on anxiety were roughly 0.3 to 0.4 standard deviations — comparable to some prescription antidepressants for mild-to-moderate cases. Cochrane reviews have generally supported these findings.

MBSR is not a cure for severe anxiety disorder, major depression, or chronic pain conditions. It is a defensible adjunct or alternative for mild-to-moderate presentations, and it produces effect sizes that clinicians consider meaningful.

2. Mindfulness-Based Cognitive Therapy (MBCT)

An extension of MBSR designed specifically to prevent depression relapse. Combines mindfulness training with cognitive therapy techniques. Kuyken et al. (2015) published a large trial in The Lancet showing MBCT was as effective as maintenance antidepressant medication in preventing depression relapse, with fewer side effects. Subsequent trials and meta-analyses have generally supported these findings.

For patients with recurrent depression, MBCT is one of the more evidence-based non-pharmacological interventions available. It is typically delivered as an 8-week structured program by trained clinicians rather than self-practiced from an app.

3. Transcendental Meditation (TM)

A specific mantra-based practice with a substantial trial base, largely funded by the TM organization. This funding structure creates real methodological caution, but the trial base is large enough that some findings have been independently replicated.

The AHA (American Heart Association) in 2013 published a scientific statement finding TM had reasonable evidence for reducing blood pressure — a Class IIB recommendation for consideration as a possible adjunct in hypertension management. Effect sizes are modest (a few mmHg systolic) but consistent enough to warrant the recommendation. This is one of the few meditation practices with a specific cardiovascular endpoint that has cleared institutional endorsement.

TM is proprietary — you learn it from certified teachers who charge substantial fees. The mantras and technique are not published freely. Whether TM-specific effects exceed what other mantra-based practices produce is not clearly established. What is established is that regular practice of a mantra-based technique for 20 minutes twice daily produces measurable blood pressure reductions.

4. Body scan meditation

A component of MBSR and a standalone practice with its own trial base. The practice involves systematically directing attention to different regions of the body, noticing sensations without attempting to change them. Duration typically 20 to 45 minutes.

Studies specifically on body scan practice show measurable benefits for chronic pain, particularly fibromyalgia and chronic low back pain. Effect sizes are comparable to MBSR broadly, and body scan is one of the components most consistently associated with pain-related benefit in dismantling studies of MBSR.

What the meta-analyses actually support

Goyal 2014 remains a useful summary of the state of the field. The evidence-supported outcomes for meditation programs of adequate structure and duration:

• Anxiety. Moderate effect sizes for MBSR and MBCT.
• Depression. Moderate effect sizes; MBCT particularly supported for relapse prevention.
• Pain (chronic non-cancer pain). Small-to-moderate effect sizes for MBSR and body scan.
• Stress and quality of life. Modest but consistent effects.
• Blood pressure. TM specifically supported for modest reductions.

Outcomes where evidence is weaker or absent:

• Attention and executive function in healthy adults. Some acute effects, mixed evidence for lasting improvements.
• Sleep. Modest effects, not clearly superior to other relaxation practices.
• Substance use disorders. Preliminary support, evidence base still developing.
• Weight management, eating behavior, addictions. Some support for mindfulness-based interventions but effect sizes small.
• Physical health outcomes beyond blood pressure. Interesting preliminary findings on inflammation, immune function, and telomere length. Trial base not yet strong enough for definitive claims.

The dose-response question

Most positive trials use programs of 8 weeks with 20 to 45 minutes of daily practice. That is a substantial time commitment. Whether shorter durations produce proportional benefits is less clear.

What limited evidence supports:

• Daily practice of any duration is better than sporadic longer practice. Consistency appears to matter more than session length within reasonable ranges.
• 10 minutes daily produces measurable effects on stress and anxiety. Trials of shorter durations have shown effects, though usually smaller than trials of 20 to 45 minutes.
• Below 5 minutes daily, the effects are inconsistent. Very short practices do not appear to produce the same chronic changes as longer ones.
• Beyond 45 minutes daily, additional practice does not clearly produce proportional additional benefit in most trials.

What meditation is doing biologically

The proposed mechanisms — none fully settled — include:

• Reduced default mode network activity. Neuroimaging shows meditators exhibit reduced activity in the default mode network — the neural network associated with self-referential thinking and mind-wandering. Whether this reduction is the mechanism of benefit or an incidental finding is unclear.
• Increased grey matter density in specific regions. Hlzel et al. (2011) reported increased grey matter density in the hippocampus, posterior cingulate, and temporo-parietal junction after 8 weeks of MBSR. Effect sizes were small and the replication picture is imperfect.
• Altered HPA axis reactivity. Some evidence for blunted cortisol response to acute stressors in regular meditators.
• Increased HRV. Some evidence for improved vagal tone at rest.

The mechanism story is a research area, not a definitive claim base. What is clearer is the clinical outcome evidence: several forms of meditation reliably move anxiety, depression, and pain scores in modest but meaningful ways.

The app question

Meditation apps (Headspace, Calm, Waking Up, Ten Percent Happier) have made meditation more accessible than the original MBSR courses. Whether app-delivered meditation produces the same effects as in-person structured programs is a legitimate question.

Some studies specifically on app-delivered meditation show meaningful effects — Chittaro and Vianello 2016, and Flett et al. 2019 among others. Effect sizes are typically smaller than in-person MBSR trials, which may reflect lower adherence in unsupervised app use or differences in program depth. But apps produce real effects for real users, and the accessibility gain probably outweighs the per-user effect-size loss at the population level.

Practical guidance: an app-delivered daily practice is a defensible starting point. If mental health concerns are meaningful, a structured in-person MBSR or MBCT program with a trained instructor is preferable.

Complementary tools

The Sam Harris framework: attention versus contentment

Sam Harris and the tradition he draws from make a useful distinction that maps onto the trial base. Meditation can be framed two ways:

• Attention training. Practices that develop the capacity to notice and redirect attention. Correlates strongly with the mindfulness-based trial base — MBSR, MBCT, standard mindfulness meditation.
• Insight practice. Practices that investigate the felt sense of self and produce lasting shifts in baseline experience. Correlates with the more traditional Buddhist frameworks and appears to require substantially more time to yield lasting changes.

The trial base is heaviest on the attention-training side. Most trials involve programs of 8 to 12 weeks with 20 to 45 minutes daily practice — a dose that develops noticeable attention improvements and produces the modest anxiety, depression, and pain benefits documented in the meta-analyses. The insight-practice side generally requires months or years of substantial daily practice to produce the lasting shifts practitioners describe, and its trial support is thinner.

Both are defensible. The attention-training side has more evidence and a shorter time-to-benefit; the insight side has more traditional support and appeals to practitioners interested in the deeper claims of contemplative traditions.

What the marketing overreaches

• Curing anxiety, depression, or PTSD. Meditation is a defensible component or adjunct. It is not a substitute for evidence-based treatment for severe conditions.
• Extending lifespan measurably. Preliminary findings on telomere length and inflammation markers are interesting. The claim that meditation extends healthspan or lifespan is beyond current evidence.
• Curing chronic disease. No.
• Producing enlightenment reliably. This is not a testable claim within the evidence-based framework and mostly should not be sold as a marketing promise.
• Rapid, dramatic mental state changes from short-format practice. Effect sizes in trials are moderate, not transformative.

A 12-week beginner protocol

Weeks 1 to 4: Establish daily practice

1. 10 minutes daily. Same time each day, ideally morning.
2. Choose one practice and stick with it for the four weeks — mindfulness of breath is a defensible default.
3. Do not evaluate whether it is working during this window. Focus only on showing up.

Weeks 5 to 8: Extend duration and add body scan

1. 20 minutes daily. Sit for 15 minutes in your primary practice; add 5 minutes of body scan.
2. Begin tracking subjective stress and mood on a simple 1-10 scale morning and evening.
3. Notice attention drift honestly — the practice is not failing when your mind wanders. Noticing the wander and returning is the practice.

Weeks 9 to 12: Evaluate and decide

1. Continue 20 minutes daily.
2. Compare your week 5 mood/stress data to week 12 data. Look for shifts in average, not just single days.
3. Consider whether a structured MBSR or MBCT program in your community would be a next step. The effect sizes for structured 8-week programs exceed what most self-directed app practice produces.

Honest limitations

Meditation is not free of risk. A small minority of practitioners — particularly during intensive retreats or with pre-existing mental health conditions — experience destabilizing effects that require support to resolve. Britton and colleagues have documented these adverse effects and pushed the field to acknowledge them. This is not a reason to avoid meditation. It is a reason to approach intensive practice with informed guidance and to seek professional support if a practice produces sustained distress.

For most people, most of the time, meditation is a low-risk intervention with modest documented benefits. The claim that everyone should meditate is defensible; the claim that meditation will resolve serious mental health conditions on its own is not.

The honest bottom line

Meditation has grown into one of the better-supported non-pharmacological interventions for anxiety, depression relapse prevention, chronic pain, and (specifically for TM) blood pressure. Four practices — MBSR, MBCT, TM, and body scan — carry the strongest evidence. Daily practice of 10 to 45 minutes produces measurable effects over 8 to 12 weeks. App-delivered practice is a defensible starting point; structured in-person programs produce larger effects for clinical concerns. Marketing continues to overreach beyond what trials support, but the trial-supported claims are already enough to justify the practice. Pick one of the four evidence-supported techniques, commit to a daily practice, and expect a modest but real change in your baseline stress response and mood over 8 to 12 weeks. The intervention is free, the evidence is real, and the barrier is just consistency.